Agten, Sven; Wu, Ben - 2024
Chapter 1: The Chinese healthcare and pharmaceutical market: Ignore at your own peril -- Chapter 2: China regulatory …-in-class -- Chapter 5: The art of the biopharma deal: The China angle -- Chapter 6: End if the first cycle. A drastic rest, future … and boom cycle, long-term perspectives, and how as a foreign company or investor to tap into this. China has gone from a …